Lipid Analysis Devices Market Revenue Growth Predicted by 2026

Lipid Analysis Devices Market Revenue Growth
Predicted by 2026
Lipid Analysis Devices Market - By Application (Hyperlipidemia,
Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia,
and Tangier Disease), By Type (Clinical Analyzer and Point-of-care devices), and
By End Users (Hospitals, Diagnostic clinics, and Homecare settings) - Global
Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
The lipid analysis devices are used for measuring elevated plasma cholesterol or triglycerides or low
level of high-density lipoprotein (HDL). The determination of blood lipid levels is important for
monitoring the risk of cardiovascular disease. Lipid analysis device is used for detection of
hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, and tangier disease.
Lipid analysis device can be implemented at the clinics or it can be a point-of-care device. Point-ofcare device has wider application as compared to clinical analyzers due to its low cost, accuracy, ease
of use, and rapidity of producing results. The lipid analysis devices market is propelled by rising
incidence of abnormal levels of lipids and technological advancements while factors such as high
pricing of clinical based analyzers and stringent as well as time consuming regulatory policies are
expected to hamper growth of Lipid Analysis Devices Market.
Lipid Analysis Devices Market Drivers
The lipid analysis test results were subjected to many drawbacks during patient handling such as
inaccuracy in the results due to improper fasting and medications, human error, and various other
factors, which gives false negative or false positive results. Therefore, to overcome such drawbacks,
lipid analysis market demands for new technology-based devices, which will propel growth of lipid
analysis devices market. According to the American Diabetes Association, heart attack or stroke affect
people with diabetes more than twice as often as people without diabetes. Therefore, Polymer
Technology Systems Diagnostics, in 2013, introduced CardioChek Plus analyzer at the annual
American Association for Clinical Chemistry (AACC), which can be used for analyzing both lipid and
glucose levels simultaneously. Furthermore, the CardioChek Plus analyzer system is Wi-Fi enabled and
can transmit test results of patients to data collection applications. In 2013, Acon Laboratories, Inc.,
launched the Mission Cholesterol Monitoring system, which can perform 3 tests; total cholesterol
(CHOL), high density lipoprotein (HDL), and triglycerides (TRIG).
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/1488
Lipid Analysis Devices Market – Competitors
Polymer Technology Systems, Inc., Jant Pharmacal Corporation, Alere, F. Hoffmann-La Roche Ltd.,
Acon Laboratories, Inc., and Cholestech Corporation are some of the major players in the lipid analysis
devices market. The strategies such as merger, acquisition or collaboration by key players will expand
the lipid analysis devices market. For instance, in 2014, Polymer Technology Systems Inc. signed
distributor agreement with Hanson Medical Systems, Inc. for domestic sales of products, which
includes marketing, selling, and distributing of the CardioChek family of products to the customers.
Lipid Analysis Devices Market – Regional Analysis
On the basis of region, the global lipid analysis devices market is segmented into North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa. Lipid analysis devices market is predominant
in Europe region due to sedentary lifestyle and high fat diet, which contributes to increasing incidence
of abnormal levels of lipid leading to cardiovascular disease. According to the World Health
Organization (WHO), in 2008, around 133 million people suffered from bad cholesterol in 5 economies
of European Union, which includes Germany, France, Italy, Spain, and UK. Moreover, Asia Pacific is
expected to be the fastest growing lipid analysis devices market region due to increasing healthcare
awareness and diagnostic demand.
According to the Centers for Disease Control and Prevention (CDC), in 2015, high blood cholesterol
was the leading cause of death in the U.S. and people with high cholesterol had about twice the risk of
heart disease, as compared to people with lower cholesterol level. Such high prevalence of high
cholesterol and coronary heart disease globally is expected to propel growth of the lipid analysis device
market. Furthermore, increasing awareness of lipid analysis devices especially kits among the
population is expected to drive growth of the market.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]

The lipid analysis devices are used for measuring elevated plasma cholesterol or triglycerides or low level of high-density lipoprotein (HDL). The determination of blood lipid levels is important for monitoring the risk of cardiovascular disease.

Download Report